ORIGINAL RESEARCH
Published on 09 Aug 2022
Neuronal MD2 induces long-term mental impairments in septic mice by facilitating necroptosis and apoptosis
doi 10.3389/fphar.2022.884821
- 3,595 views
- 9 citations
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Neuropharmacological Targets for Depressive Disorders and Seizures
Neuropharmacological Targets for Depressive Disorders and Seizures
5,898
Total downloads
21k
Total views and downloads
Articles
CASE REPORT
Published on 31 Mar 2022
Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series
doi 10.3389/fphar.2022.852042
- 6,176 views
- 3 citations
ORIGINAL RESEARCH
Published on 08 Mar 2022
Hippocampus RNA Sequencing of Pentylenetetrazole-Kindled Rats and Upon Treatment of Novel Chemical Q808
doi 10.3389/fphar.2022.820508
- 2,281 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Feb 2022
Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
doi 10.3389/fphar.2022.765446
- 5,907 views
- 21 citations
ORIGINAL RESEARCH
Published on 18 Nov 2021
Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
doi 10.3389/fphar.2021.757417
- 2,230 views
- 7 citations
Published in
Frontiers in Neuroscience
Neuropharmacology
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore